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Synthetase at 2.3 A˚ Resolution
as one of the products. Therefore phosphopantothenate
is activated by the formation of the acyladenylate or the
acylcytidylate, which then reacts with cysteine to form
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Cornell University PPC (Figure 2). The human enzyme shows low sequence
similarity to the bacterial enzyme, suggesting the possi-Ithaca, New York 14853
bility of developing selective inhibitors of the bacterial
enzyme. Because bacteria do not have a PPC transport
system, this enzyme is potentially a good target for the
development of new antibacterials.Summary
Serine misincorporation in coenzyme A biosynthesis
would result in the formation of oxo-coenzyme A inThe structure of human phosphopantothenoylcysteine
which the cofactor thiol is replaced by an alcohol. Be-(PPC) synthetase was determined at 2.3 A˚ resolution.
cause the thiol group plays a key role in the biochemistryPPC synthetase is a dimer with identical monomers.
of this cofactor, oxo-coenzyme A is likely to inhibit cellSome features of the monomer fold resemble a group
growth. PPC synthetase shows high selectivity for cys-of NAD-dependent enzymes, while other features re-
teine over serine (our unpublished results). The mecha-semble the ribokinase fold. The ATP, phosphopanto-
nistic basis for this selectivity is a fundamental problemthenate, and cysteine binding sites were deduced from
in enzymology and is generally poorly understood. Themodeling studies. Highly conserved ATP binding resi-
only relevant structural study was carried out on the cystei-dues include Gly43, Ser61, Gly63, Gly66, Phe230, and
nyl-tRNA synthetase, where the selectivity results primarilyAsn258. Highly conserved phosphopantothenate bind-
from the coordination of the cysteine thiol to an active siteing residues include Asn59, Ala179, Ala180, and Asp183
zinc ion (Newberry et al., 2002). The structural studiesfrom one monomer and Arg55 from the adjacent mono-
described here allow us to examine some of the possiblemer. The structure predicts a ping pong mechanism
mechanisms for this selectivity in PPC synthetase.with initial formation of an acyladenylate intermediate,
Most of the structures from the pantothenate and co-followed by release of pyrophosphate and attack by
enzyme A biosynthetic pathways have been determinedcysteine to form the final products PPC and AMP.
by X-ray crystallography. These include ketopantoate
hydroxymethyltransferase (Protein Data Bank ID code
Introduction 1M3U), ketopantoate reductase (Matak-Vinkovic et al.,
2001; PDB 1KS9), aspartate-1-decarboxylase (Albert et
Coenzyme A and phosphopantetheine function as acyl al., 1998; PDB 1AW8), pantothenate synthetase (von
carriers and as carbonyl activating groups for Claisen Delft et al., 2001; PDB 1IHO), pantothenate kinase (Yun
condensations, as well as for amide, ester, and thioester et al., 2000; PDB 1ESN), PPC decarboxylase (Albert et
forming reactions. These cofactors play a key role in al., 2000; Kupke et al., 2001; PDB 1E20), phosphopan-
the biosynthesis and breakdown of fatty acids, in the tetheine adenylyltransferase (Izard and Geerlof, 1999;
biosynthesis of nonribosomal peptides and polyketides, PDB 1QJC), and dephosphocoenzyme A kinase (Obmo-
and in many other biochemical pathways. lova et al., 2001; PDB 1JJV). Here we report the structure
Coenzyme A is biosynthesized from phosphopanto- of human PPC synthetase, the remaining unknown
thenate in all organisms using four enzymatic steps structure in the biosynthesis of coenzyme A, provide
(Begley et al., 2001; Figure 1). Phosphopantothenoylcys- models for the substrate binding sites, and identify key
teine (PPC) synthetase catalyzes the first step. Although active site residues.
the coenzyme A biosynthetic pathway is well estab-
lished, the gene for PPC synthetase was only recently
identified (Daugherty et al., 2002; Kupke, 2002; Strauss Results
et al., 2001). In humans, PPC synthetase and PPC decar-
boxylase, the next enzyme in the pathway, are encoded Description of the Final Model
by separate genes, coaB and coaC, respectively, while in The crystal structure of human PPC synthetase was
some bacteria (e.g., Escherichia coli) these genes are fused. determined by single wavelength anomalous dispersion
Human PPC synthetase contains 311 amino acid resi- methods using selenomethionine (SeMet)-labeled pro-
dues and functions as a dimer (Daugherty et al., 2002). tein. The final model, refined at 2.3 A˚ resolution, includes
The bifunctional bacterial enzymes contain about 400 two monomers designated A and B, which are related
residues of which about 250 at the C terminus align with by 2-fold noncrystallographic symmetry. The model in-
human PPC synthetase. The PPC synthetase from the cludes 549 amino acids, two sulfate anions, and 218
bifunctional E. coli enzyme is also a dimer when ex- water molecules. Residues 1–17, 111, 188–201, 260–
pressed separately (Kupke, 2002). The human enzyme 265, and 308–311 of monomer A and residues 1–6, 108–
requires ATP and produces AMP as one of the products, 112, 192–202, 260–264, and 308–311 of monomer B are
while the E. coli enzyme utilizes CTP and produces CMP disordered in the electron density maps and hence not
built into the model.
The crystal structure confirms that PPC synthetase is*Correspondence: see3@cornell.edu
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central  sheet. Two additional  strands (2 and 3)
are joined by a short loop. One sulfate anion was located
in monomer B and a second sulfate ion was located
about 5 A˚ from the noncrystallographic 2-fold axis. Tyr92
from each monomer has main chain torsion angles that
lie in the disallowed region of the Ramachandran plot.
The conformation of Tyr92 was verified to be consistent
with the electron density maps.
Dimer Interface
The active form of PPC synthetase is a dimer with the
approximate dimensions 60 A˚  60 A˚  75 A˚ (Figure 4).
The subunit interface in the dimer is composed of two
regions. The first region is formed by the interactions
between helices 3103, 4, and 5 from each of the mono-
mers. In the second region, strands 2 and 3 of one
monomer interact with the 2-fold-related strands on the
other monomer to form a small, twisted antiparallel 
sheet. Additional interactions of loops occur between
amino acid residues 203–208 in each monomer. The
dimer interface buries a total surface area of 4581 A˚2.
The monomers form 28 hydrogen bonds between side
chains at the interface. In addition, four water molecules
bridge amino acid residues between the two monomers.
A cluster of hydrophobic residues forms in the core of
the dimer interface. The cluster includes 2-fold-related
pairs of Phe96, Trp101, Leu125, and Phe128. The aro-
matic rings of the Trp101 pair are approximately parallel
to each other and are separated by about 4.5 A˚, and
the other 3 residues flank the central pair.
Comparison of Monomers A and B
A comparison of PPC synthetase monomers A and B
showed an rms difference of 0.4 A˚ for 219 of 264 pairs of
ordered C atoms; however, two other segments show
significant differences. Residues 230–253 (7, 9, and
the loop connecting them) show an rms difference ofFigure 1. Universal Pathway for the Biosynthesis of Coenzyme A
3.7 A˚. The difference is probably the result of differences
in crystal packing. The rms difference for residues 210–
219 is 4.4 A˚. These residues are affected by interactionsa homodimer. The overall fold of the monomer is an 
with helix 9 and are therefore an indirect result of crys-three-layer sandwich (Figure 3). Monomer A contains
tal packing.seven  helices, three 310 helices, and ten  strands.
Helix 8, which is a 310 helix in monomer A, is a short
 helix in monomer B. Each monomer contains a central Conserved Active Site Residues
Comparison of the representative sequences of PPCeight-stranded  sheet with topology 5↑4↑1↑6↑7↑8↑9↓10↑.
Three  helices (1, 6, and 9) flank one side of the synthetases from both monofunctional and bifunctional
enzymes using CLUSTALW (Thompson et al., 1994)sheet and the remaining four  helices (2, 4, 5, and
10) are on the opposite side. All the  helices except identified 17 residues that are completely conserved
(Figure 5). These residues lie along a cleft that is large5 are approximately antiparallel to the strands of the
Figure 2. Mechanism of PPC Formation
In the human PPC synthetase reaction, the carboxylate of phosphopantothenate is activated by ATP to form an acyladenylate intermediate,
followed by addition of cysteine and release of AMP to form the final product.
Structure of Phosphopantothenoylcysteine Synthetase
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Figure 3. Structure of the PPC Synthetase Monomer
(A) Stereo view of the PPC synthetase monomer with every tenth residue labeled.
(B) Topology diagram of PPC synthetase is shown with the first and last residue number labeled for each secondary structural element.
(C) Ribbon representations of the monomer. The helices and strands are numbered A1–A10 and B1–B10, respectively. The figure was prepared
using MOLSCRIPT (Kraulis, 1991) and Raster3D (Merritt and Bacon, 1997).
The dotted line depicts the disordered loops. The  helices are shown in green, 310 helices in cyan, and  strands in blue.
enough to simultaneously accommodate ATP and phos- basso et al., 2000) and other members of the ribokinase
phopantothenate (Figure 6). Two of the conserved resi- family. A structural comparison using DALI (Holm and
dues, Val54 and Arg55, are provided by the adjacent Sander, 1993) showed the highest similarity (Z  7.9)
monomer and are located on a loop that forms part between PPC synthetase and 3-hydroxy-CoA dehydro-
of the dimer interface. The sequence alignment also genase (PDB 1E6W; Powell et al., 2000) and several
indicates a deletion of about 60 residues in the bifunc- other NAD-dependent enzymes. The DALI search also
tional enzymes relative to the monofunctional enzyme. indicated similarity (Z  6.5) between ADP-dependent
In human PPC synthetase, these residues correspond to glucokinase (PDB 1GC5; Ito et al., 2001) and other mem-
a long loop beginning after strand 4 and including helices bers of the ribokinase family.
3–5 and strand 5. The residues at the beginning and end The ribokinase fold was first identified in a family of
of this loop, Ala86 and Thr150, are close together in the ATP-dependent carbohydrate kinases (Bork et al., 1993;
three-dimensional structure, suggesting that excision of Wu et al., 1991) and later shown to include other small
the loop would not affect the overall fold. molecule kinases for which phosphorylation occurs at
a hydroxymethyl group of the substrate molecule
(Cheng et al., 2002). While the ribokinase family enzymesDiscussion
catalyze the ATP-dependent phosphorylation of a hy-
droxymethyl group, PPC synthetase catalyzes the ade-Similarity with Other Protein Structures
nylation of the phosphopantothenate carboxylate group.A structural comparison using DEJAVU (Madsen and
The similarities between PPC synthetase and the riboki-Kleywegt, 2002) revealed a high similarity in the arrange-
nase family structures result from their common depen-ment of secondary structural elements between PPC
synthetase and hydroxyethylthiazole kinase (Campo- dence on ATP. However, the differences in catalytic
Structure
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Rationale for Substrate Modeling
Despite extensive efforts, we were unable to prepare
crystals of a complex of PPC synthetase with ATP, sub-
strates, or analogs. The crystals were grown in the pres-
ence of ammonium sulfate, which may have prevented
the binding of ATP and analogs. It is also possible that
substrate binding requires conformational changes that
are prevented by crystal packing. Conformational
changes upon substrate binding are observed in several
members of the ribokinase family, including ribokinase
(Sigrell et al., 1999), adenosine kinase (Schumacher et
al., 2000), and ADP-dependent glucokinase (Tsuge et
al., 2002).
The similarity between the ATP binding domains of
PPC synthetase and the ribokinase family allowed us to
model an ATP molecule into the active site. Adjacent to
the ATP binding site is a narrow cleft that is the correct
size and shape to accommodate PPC in an extended
conformation. This cleft includes conserved residuesFigure 4. Structure of PPC Synthetase Dimer, Viewed along the
from both monomers and was inferred to be the PPCNoncrystallographic 2-Fold Axis
binding site. The cysteine binding is inferred from theEach monomer is shown in a different color. Sulfate ions are shown
as ball and stick models. The N and C termini of each monomer are requirement that the acyladenylate intermediate forms
labeled. Secondary structural elements near the dimer interface are before attack by cysteine. The cysteine binding site is
also labeled. The figure was prepared using MOLSCRIPT (Kraulis, proposed to be located near the only active site entry
1991) and Raster3D (Merritt and Bacon, 1997).
point that remains after ATP and PPC binding occurs.
Several conserved residues are also located in this area
of the active site.
function and substrate specificity result in structural di-
vergence.
ATP Binding Site
Comparison of the C positions of PPC synthetase
The model structure showed that the ATP molecule is
with those of hydroxyethylthiazole kinase showed close
located near the ends of strands 1, 6, 7, 8, and 9
agreement for the central  sheet and most of the flank-
and helices 2 and 10. Conserved residues Phe230
ing  helices (Figure 7A). The ATP binding motif of the
and Asn257 are positioned near the adenosyl moiety of
ribokinase family appears to be structurally conserved in
the ATP molecule. Also in the ATP binding site, Tyr176
PPC synthetase, including five  strands (1, 6, 7, 8,
is conserved in the monofunctional PPC synthetases
and 9) and two  helices (2 and 10); however, there
but is isoleucine in the bifunctional enzymes, which pre-
is very low sequence identity. Comparison of the corre-
fer CTP over ATP. The ATP -phosphate is located near
sponding folding topologies shows both similarities and
one of the sulfate anions present in the structure. Based
differences (Figure 7B). The topology of the C-terminal
on the model, the - and -phosphates are expected to
ATP binding domain of PPC synthetase closely resembles
interact with residues 61–66 while the -phosphate is
that of the ATP binding domain of the ribokinase family.
expected to interact with Gly43, which is also absolutely
The main differences in folds between the ribokinase
conserved. The dipole of helix 2 (residues 64–75) is
core and human PPC synthetase occur in the N-terminal
oriented such that the N terminus is directed toward the
portion of the  sheet adjacent to the ATP binding do-
-phosphate group.
main. The N-terminal portion of the molecule resembles
the NAD binding enzymes. Strands 1, 4, and 5 and
Phosphopantothenate Binding Sitehelices 2 and 3 (Figure 3B) have the topology of the
The predicted phosphopantothenate binding site is lo- unit found within dinucleotide binding domains
cated in a cleft formed largely by the C-terminal ends(Rao and Rossmann, 1973). Helix 2 contains a GRxG
of strands 6 and 7. Conserved residues Thr45, Asn59,motif at its N terminus, which interacts with phosphate,
Ala179, and Ala180 from one monomer and Val54 andand is found in several of the NAD-dependent enzymes
Arg55 from the adjacent monomer are positioned nearrevealed in the DALI search. The 2 helix dipole is also
the proposed bound phosphopantothenate. Arg55 is posi-oriented to stabilize the -phosphate of ATP.
tioned to form a hydrogen bond with the phosphate, whileWithin the ribokinase family, the N-terminal portion of
the carboxylate group is near the -phosphate of ATP.the fold also shows greater structural variation than the
C-terminal portion. In this case, the N-terminal residues
contribute primarily to substrate binding specificity Cysteine Binding Site
(Cheng et al., 2002) and are a hot spot for change, while Positioning of ATP and phosphopantothenate in the ac-
the C-terminal portion of the fold is less variable and tive site accounts for nearly all of the accessible volume,
forms the ATP binding domain. The structure of PPC and almost all of the highly conserved residues in the
synthetase demonstrates that the ATP binding domain active site are associated with ATP or phosphopanto-
of the ribokinase family is more widely distributed than thenate binding. This suggests that a cysteine molecule
can only be accommodated after the AMP-phosphopan-originally thought.
Structure of Phosphopantothenoylcysteine Synthetase
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Figure 5. Sequence Alignment for Monofunctional and Bifunctional PPC Synthetases
Human, mouse, A. thaliana, fowl poxvirus, fruitfly, C. elegans, and yeast PPC synthetases are monofunctional. T. maratima, B. subtilis, E. coli,
and M. jannaschii PPC synthetases form the C-terminal domain of the bifunctional PPC synthetase/decarboxylase. Secondary structural
elements based on the human structure are shown on the top line (,  helix; ,  strand; , 310 helix). Residues that are absolutely conserved
in all species are highlighted in red boxes. Residues that are nearly conserved are highlighted in red letters. The sequence alignment was
performed using CLUSTALW (Thompson et al., 1994) and the figure was prepared using ESPrit (Gouet et al., 1999).
tothenate intermediate forms and pyrophosphate is re- chain is pointed away from the active site in the unli-
ganded PPC synthetase structure.leased through an opening near residues 61–66. This
opening also provides the most likely access to the
active site for the cysteine molecule that adds in the Correlation of Structure with Site-Directed
Mutagenesis Studiessubsequent step. Possible residues associated with
cysteine binding are residues that become available Mutational studies on the PPC synthetase domain of
the bifunctional E. coli enzyme, carried out prior to theafter pyrophosphate is released. Glu233, which is lo-
cated in a flexible loop near the active site opening, is availability of the structure, identified amino acid resi-
dues that are important for dimerization and residuesconserved in all PPC synthetases; however, the side
Structure
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Figure 6. Active Site Model
(A) Stereo view of the active site model of
human PPC synthetase showing conserved
residues. The model for the reactants was
constructed using the ribokinase family to
position the ATP molecule. The phosphopan-
tothenate molecule was positioned in a cleft
lined with conserved active site residues ad-
jacent to the ATP binding site. The carboxyl-
ate group was positioned near the ATP site
and the phosphate group was positioned
away from the ATP site with the geometry
expected for the chemical reaction.
(B) Stereo view of the van der Waal’s surface
near the active site. The model of the acylade-
nylate intermediate was created by joining
the ATP and phosphopantothenate shown in
(A) followed by energy minimization to re-
move bad contacts. The conserved residues
are color coded by amino acid type (green,
hydrophobic; red, negatively charged; blue,
positively charged). Arg64 and Arg65 are lo-
cated above the ATP phosphate groups and
were removed for clarity. The figure was pre-
pared using MOLSCRIPT (Kraulis, 1991),
Raster3D (Merritt and Bacon, 1997), and
SPOCK (Christopher, 1998).
that are important for PPC synthetase activity (Kupke, tation led to complete loss of PPC synthetase activity.
The mutant N210D was able to form the CMP-phospho-2002). Seventeen mutants were prepared and tested for
changes in oligomeric state using gel filtration. Mutation pantothenate intermediate (the E. coli enzyme uses CTP
in place of ATP) but did not form product. Based onof residues corresponding to Thr41(194), Thr45(198),
Glu50(203), Asn59(210), and Ala179(275) in human PPC these studies, Kupke proposed that the N210D mutation
either impairs binding of cysteine or influences the nu-synthetase resulted in changes in elution behavior, sug-
gesting a role for these residues in dimer stabilization cleophilic attack on the intermediate by cysteine. It was
also proposed that Lys289 may be involved in binding(numbers in parentheses refer to E. coli numbering). In
the human PPC synthetase structure, residues 46–62 are the phosphate group of either phosphopantothenate or in
binding the phosphate groups of the cofactor CTP. Thelocated in the dimer interface and sequence alignment
shows that residues Thr45, Glu50, and Asn59 are highly structure of human PPC synthetase with modeled sub-
strates does not support these functional assignments:conserved. However, Thr41 is located on strand 1 and
Ala179 is located at the C-terminal edge of strand 6, Asn59(210) interacts with the phosphate group of phos-
phopantothenate, and while the loop containing the resi-and neither is involved in the dimer interface.
Six E. coli PPC synthetase mutants, corresponding due Lys195(289) is disordered, the estimated position of the
loop places Lys195 near Asn59 of an adjacent monomer.to Asn59(210), Ser61(212), Arg64(215), Lys195(289),
Gln197(291), and Ser198(292) in human PPC synthetase,
were prepared and assayed for enzymatic activity Comparison with the Bifunctional PPC
Synthetase/PPC Decarboxylase(Kupke, 2002). Asn59, Ser61, and Lys195 are conserved
in all PPC synthetase sequences. Ser198 is conserved In some microorganisms, PPC synthetase is part of a
bifunctional enzyme containing both PPC synthetasein the monofunctional PPC synthetases, while Arg64
is not. The residues corresponding to both of these and FMN-dependent PPC decarboxylase activities. Se-
quence comparisons show that the N-terminal half ofpositions in the bifunctional PPC synthetase subtypes
are always lysines. Gln197 is not conserved in either the bifunctional enzyme aligns with human PPC decar-
boxylase, while the C-terminal half aligns with humanthe monofunctional or bifunctional subtype. The S212A,
K215Q, K291Q, and K292Q E. coli enzyme mutants PPC synthetase. The bifunctional enzyme from E. coli
forms a large complex with a molecular mass of aboutshowed conversion to product; however, detailed ki-
netic parameters were not determined. The K289Q mu- 600 kDa, consistent with a dodecameric structure (Kupke
Structure of Phosphopantothenoylcysteine Synthetase
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Figure 7. Comparison of the Topology of Hu-
man PPC Synthetase with the Core Domain
of the Ribokinase Family
(A) Stereo view of the superposition of PPC
synthetase and hydroxyethylthiazole kinase.
PPC synthetase is shown in green and hy-
droxylethylthiazole kinase is shown in red.
The secondary structural elements of PPC
synthetase are labeled. The coordinates for
hydroxyethylthiazole kinase come from PDB
1ESJ (Campobasso et al., 2000). C positions
from PPC synthetase 1, 4, 6–10, 1, 6,
and 9 were used in the superposition. These
regions include 97 C positions that superim-
pose with an rms difference of 2.3 A˚.
(B) Topology diagrams for the core domain of
the ribokinase family and for PPC synthetase.
The secondary structural elements common
to all previously described ribokinase family
members are shown (Cheng et al., 2002). The
secondary structural elements for PPC syn-
thetase are numbered. Topologically con-
served helices are shown in red (upper side)
or green (lower side) circles. Topologically
conserved strands are shown as blue trian-
gles. Triangles pointing in the same direction
represent parallel strands and triangles point-
ing in opposite directions represent antiparal-
lel strands. Topologically unique strands and
helices for human PPC synthetase are shown
in yellow.
et al., 2000). The structure of the human PPC synthetase, Mechanistic Implications
The key mechanistic question for PPC synthetase istogether with the structure of the PPC decarboxylase
homolog EpiD (Blaesse et al., 2000), allows us to infer the how the enzyme selects between cysteine and serine.
Three possible modes of discrimination can be envi-quaternary structure of the bifunctional PPC synthetase/
PPC decarboxylase. The structure of EpiD is a dode- sioned. The first is based on selective anchoring of cys-
teine at the active site by a disulfide bond or by coordina-camer with 23-point symmetry. In EpiD, the trimers
formed about the 3-fold axes are similar to the PPC tion to a zinc ion. The second is based on noncovalent
interactions such as hydrophobic interactions, the weakerdecarboxylase trimers observed in Arabidopsis thaliana
(Albert et al., 2000). Furthermore, the E. coli PPC synthe- hydrogen bonding of thiols compared to alcohols, and
the larger size of sulfur compared to oxygen (covalenttase domain expressed alone was shown to be a dimer
(Kupke, 2002). These observations suggest that the bi- radius of sulfur is 1.04 A˚, compared to 0.66 A˚ for oxygen).
The third exploits the greater nucleophilicity of thiolsfunctional enzyme consists of a PPC decarboxylase
core having 23-point symmetry and that the PPC synthe- over alcohols and would give a thioester intermediate
that could then rearrange to the amide. The three-dimen-tase domains form an outer layer in which the dimers
are oriented along the 2-fold axes, bridging the trimers. sional structure of human PPC synthetase shows no
cysteine residue near the active site and no evidenceThe modeled structure of the bifunctional enzyme (Fig-
ure 8) places the C terminus of each PPC decarboxylase for a metal ion. Therefore, cysteine selection by the
anchoring of the thiol at the active site via a disulfidedomain near the N terminus of a PPC synthetase domain
as would be required for a single polypeptide chain. In bond or by coordination to a zinc ion is not possible.
The position of the cysteine in the active site is notthis model, the two active sites are near each other and
are joined by an internal channel. Neither active site is associated with any highly conserved residues. Glu233
is near the active site opening and could serve to orientoccluded by dodecamer assembly.
Structure
934
Figure 8. Proposed Structure of a Bifunctional PPC Synthetase/PPC Decarboxylase
(A) Ribbon diagram of the dodecamer viewed down the 3-fold axis.
(B) Ribbon diagram of the dodecamer viewed down the 2-fold axis. The PPC decarboxylase domain is shown in green and the PPC synthetase
domain is shown in red.
For the production of SeMet-incorporated protein, the cell growththe amino acid substrate but would first require a confor-
conditions were similar to those described above. The 1 L of growthmational change. However, we have not yet been suc-
medium contained M9 salts supplemented with 40g/ml of all aminocessful in obtaining crystals of the enzyme with substrate
acids except L-methionine, which was replaced with L-SeMet, 0.4%
or product bound at the active site, and the accuracy of (w/v) glucose, 2 mM MgSO4, 25 g/ml FeSO4·7H2O, 1 mM CaCl2,
our modeling does not allow us to differentiate between 100 g/ml ampicillin, and 1% BME vitamin solution (GIBCO-BRL).
The purification procedure for the SeMet protein was essentiallymechanisms 2 and 3. Therefore, a clear answer to the
the same as the native enzyme except that 5 mM -mercaptoethanolmechanism of selective cysteine incorporation awaits a
was added to all buffers. The final storage buffer contained 10 mMstructure with a substrate analog bound at the active site.
Tris-HCl (pH 8.0) and 2 mM dithiothreitol.
Experimental Procedures
Crystallization
PPC synthetase was crystallized using the hanging drop method,Protein Expression and Purification
with each drop containing 1 l of 8 mg/ml protein and 1 l ofThe human coaB gene was cloned into a pPROEX-Hta vector (In-
reservoir solution. The optimized reservoir solution contained 24%vitrogen) containing a 6-histidine tag and a tobacco etch virus (TEV)
polyethyleneglycol monomethyl ether 2000 (PEG 2K MME), 120 mMprotease cleavage site and transformed into the E. coli strain
(NH4)2SO4, and 100 mM Tris-HCl (pH 8.5). Crystals appeared as longB834(DE3) (Novagen) as described previously (Daugherty et al.,
needles and grew to their maximum size (0.06 mm  0.06 mm 2002). The native protein was obtained by inoculating 1 L of LB and
0.60 mm) in about 12 days. The crystallization conditions for the100 g/ml ampicillin with 5 ml of a saturated starter culture. The
native and the SeMet-incorporated proteins were essentially thecells were grown at 37	C until they reached OD600 0.6 and were
same except that 4 mM DTT was added for the SeMet protein.induced with 800 M isopropyl--D-thiogalactoside. The cells were
harvested after 4 hr by centrifugation at 5000  g for 10 min and
stored at 
80	C. X-Ray Data Collection and Processing
Monochromatic X-ray intensity data were measured for the nativeAll purification steps were carried out at 4	C. Cells were resus-
pended in 20 ml of wash buffer (50 mM Tris-HCl, 500 mM NaCl, and and SeMet PPC synthetase at beamline 8-BM at the Advanced
Photon Source using a Quantum 315 detector (Area Detector Sys-20 mM imidazole [pH 8.0]) and broken using a French press. The
crude extract was centrifuged and the resulting supernatant was tems Corporation). All data were collected at 100 K. For cryoprotec-
tion, the crystals were transferred to a stabilization solution similarmixed for 1 hr with 1 ml of Ni-NTA resin (Novagen) equilibrated with
wash buffer. The beads were then added to a polypropylene column to the mother liquor but with 34% PEG 2K MME. The crystals were
then frozen directly in the nitrogen stream. The crystals belong toand washed with 200 ml of wash buffer. The column was washed
with 5 ml of wash buffer containing 60 mM imidazole to remove the space group P43212 or P41212 with approximate unit cell dimen-
sions of a  73.2 A˚ and c  281.8 A˚. The crystals contain twoimpurities. PPC synthetase was eluted from the column using wash
buffer containing 200 mM imidazole. The protein was buffer ex- monomers per asymmetric unit corresponding to a solvent content
of 56%. Data for the native crystal were collected over a range ofchanged into 10 mM Tris-HCl (pH 8.0) by dialysis. In order to remove
the polyhistidine tag, the protein was incubated with TEV protease 80	 using a 0.5	 oscillation step with a crystal-to-detector distance
of 350 mm. The HKL suite of programs was used for integration and(Invitrogen) for 24 hr at 4	C. The protein mixture was then buffer
exchanged into the initial wash buffer, mixed with 500 l of Ni- scaling of the data (Otwinowski and Minor, 1997).
Following calibration of the beam using a Se foil, a fluorescenceNTA resin, and added to a polypropylene column. The purified PPC
synthetase in the flowthrough was buffer exchanged into the storage scan was taken on a SeMet PPC synthetase crystal. Data were
collected for a SeMet crystal at the wavelength corresponding tobuffer (10 mM Tris-HCl [pH 8.0]), concentrated to 10 mg/ml, and
stored at
80	C. Protein concentration was determined by the Brad- the maximum of f″ (peak) over 100	 using 30 s for each 0.5	 oscillation
with a crystal-to-detector distance of 300 mm. Bijvoet pairs wereford method (Bradford, 1976) using bovine serum albumin as the
standard. measured after each 10	 wedge using inverse beam geometry. The
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Table 2. Summary of Refinement Statistics for PPC SynthetaseTable 1. Summary of Data Collection and Processing Statistics
Resolution range (A˚) 50–2.3Se (Peak) Native
Total number of nonhydrogen atoms 4,217
Wavelength (A˚) 0.9793 0.9791 Number of protein atoms 3,986
Resolution (A˚) 2.9 2.3 Number of water atoms 218
Space group P43212 P43212 Number of ligand atoms 10
Cell dimensions (A˚) a  73.3, a  73.2, Number of reflections in refinement 34,666
c  281.7 c  281.8 Number of reflections in test set 2,491
Number of reflections 279,310 199,382 R factora (%) 22.9
Number of unique reflections 18,091 34,732 Rfreeb (%) 27.1Redundancy 15.4 (16.1) 5.7 (5.6) Rms deviation from ideal geometry
Completeness (%) 100.0 (100.0) 98.5 (99.7) Bonds (A˚) 0.01
Rsyma (%) 8.9 (21.2) 6.4 (31.3) Angles (	) 1.5
I/ 6.6 (2.0) 31.2 (6.3) Ramachandran plot
Most favored region (%) 91.7Values for the outer resolution shell are given in parentheses.
Additionally allowed region (%) 7.9a Rsym  
i
|Ii 
 I|/I, where I is the mean intensity of the
Generously allowed region (%) 0.0
N reflections with intensity Ii and common indices h, k, l. Disallowed region (%) 0.4
Average B factors
Main chain 41.9
Side chain 43.9intensity data were integrated with MOSFLM (Leslie, 1992) and
Water 43.6scaled and merged with SCALA (Evans, 1993). Details of the data
Sulfate 72.6collection and processing are given in Table 1.
a R factor =hkl||Fobs|
k|Fcal||/hkl|Fobs|, where Fobs and Fcal are observed
Structure Determination and calculated structure factors, respectively.
The initial Se atom positions were determined using Patterson meth- b For Rfree, the sum is extended over a subset of reflections (7%)
ods as implemented in SOLVE (Terwilliger and Berendzen, 1999). excluded from all stages of refinement.
Positions for seven out of the expected ten sites were identified
using single wavelength anomalous dispersion (SAD) data. The phases
obtained were used to identify the three remaining Se positions using
an anomalous difference Fourier map calculated using CNS (Bru¨nger pocket with the carboxylate end positioned with geometry appro-
priate for reaction with the -phosphate of ATP. The total surfaceet al., 1998). Calculation of electron density maps confirmed P43212
to be the correct space group. The phases were further improved area buried by the above proposed model of phosphopantothenate
and ATP bound to PPC synthetase is 1250 A˚2.by density modification using the program RESOLVE (Terwilliger
and Berendzen, 1999). The FOM increased from 0.27 to 0.58 after
density modification. The resultant electron density map was readily Acknowledgments
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